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INTRODUCTION:
Amyotrophic lateral sclerosis (ALS) is a progressive disease of 
motoric nerve cells in the brain cortex (upper motoric neurons), 
and in the spinal cord and the medulla (lower motoric neurons). 
That is why ALS is sometimes also referred to as the Motor Neu-
rone Disease (MND), although ALS actually is only one of the 
forms of MND. In other cases namely, either the lower or the upper 
motor neurones are damaged. In Europe, the eponymic name of 
the disease is sometimes used – Charcot’s disease (after Jean Mar-
tin Charcot, who described the disease in the summer of 1869). In 
the USA the disease is referred to as Lou Gerhig’s disease (after a 
famous baseball player who was stricken with MND in 1933).
Most commonly the muscular weakness, as a consequence of loss 
of motoric nerve cells is shown in the limbs (in 70 %), and more rare-
ly (in 30 %) in swallowing and/or speech disorders. Men are more 
likely to contract the disease. The incidence of the disease grows with 
age, too. The disease’s prevalence is 6 to 8 patients in a population 
of 100.000, and the incidence from 1,5 to 2 on 100.000 inhabitants 
annually. Five to 10% of the patients contract a hereditary for of the 
disease; in some 20% of these patients it is possible to establish a 
mutation on the gene for superoxide dismutation (SOD1). 2-3% of 
sporadic ALS patients also show the same genetic mutation.
The most typical first sign of the disease is the loss of strength 
in the muscles of one limb. The weakening then gradually affects 
the neighbouring muscles, then muscles on the other part of the 
body, and finally the muscles involved in breathing, speech and 
swallowing. Other signs of the disease include clumsiness in han-
dling objects and a slowness of movements, fatigue, muscles at-
rophy, spasms, cramps, fasciculation in muscles and other. Signs 
showing that other parts of the brain cortex have been affected 
(e.g. problems with memorizing, intelligence, inner speech...) are 
exceptions. Eye movements, urinal and faecal continence and the 
sensory system are normally not affected. Problems that are not a 
direct consequence of muscles’ weakness like depression and anxi-
ety, sleeping disorders, constipation, hypersalivation, symptoms of 
chronic breathing weakness and pain can significantly decrease the 
quality of life in singular phases of the disease. 
The origins of ALS are not known, and several hypotheses ex-
ist. Some of the possible explanations are excitotoxic damage of 
nerve cells, disorders of the immune system, infections, lack of 
neurothrophic factors, poisoning, disorders in hormonal activities 
and disorders in the activities of mitochondrions. The only known 
cause is the already mentioned mutation on the SOD1 gene. The 
excitotoxic theory is based on the hypothesis that the accumulation 
of excitatory neurotransmitters of glutamates causes the destruc-
tion of nerve cells. The immunological hypothesis assumes that 
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antibodies are created acting then against normal motoric nerve 
cells destroying them eventually. Viruses are also mentioned as the 
possible cause of ALS, among them the virus causing poliomyelitis, 
HIV and other. The poisons could include some chemical elements 
like lead, aluminium, manganese, calcium, selenium. Nerve cells 
need several neurothrophic factors for their development and ex-
istence; the lack of these factors could lead to a premature death 
of cells.
The ALS diagnosis is based on a clinical neurological examina-
tion. In order to confirm the diagnosis and in order to exclude oth-
er diseases, some other laboratory tests are run, most commonly 
electromyography, visual tests and tests of the cerebrospinal fluid. 
The diagnostic categories include convincing, probable, possible 
and suspect ALS.
The age of patients at the start of the disease is mostly over 40, 
the average age approximately 58 years. It is impossible to give pre-
cise predictions on the natural flow of the disease for each singu-
lar patient. Although ALS is considered a disease connected with 
short-time survival (an average of 3-4 years), it must be noted here 
that approximately 25% of the patients live for more than 5 years 
after the diagnosis, and 10% of the patients over 10 years.
There has been a real explosion of information on different 
views of the ALS in the last decade, ranging from pathogenesis 
to treatment. Patients’ care has become more complex and some 
communities found special centres based on a multidisciplinary 
approach. So far, a drug that would stop or alter the course of the 
disease, does not exist. The drug Riluzol has been available since 
1995, prolonging the average survival of ALS patients for several 
months. Despite of these facts, therapeutical nihilism is not jus-
tifiable. There are namely numerous ways of palliative cure that 
could significantly improve the quality of life of patients and their 
families. It is very important to stress out that palliative cure is 
not identical to symptomatic cures nor to the cure in the terminal 
phase of the disease. The palliative treatment is a multidisciplinary 
approach starting with communication the diagnosis and ending 
with family counselling during the time of dying and bereavement. 
Several experts are included in the process (work therapists, dieti-
cians, physical therapists, speech therapists, nurses, psychologists, 
social workers, hospice employees, doctors and other volunteer lay 
persons). Many procedures in the palliative treatment have already 
been scientifically assessed. Cure recommendations have been 
drafted based on these analyses.
DIAGNOSIS COMMUNICATION 
This is the beginning of a palliative cure. A doctor, trusted by 
the patient, must communicate clearly in an open conversation 
that the disease may have different courses and that it is incurable; 
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the patient must be introduced to different forms of help. If the 
communication is ambiguous, the patient or his family might cre-
ate their own false picture of the disease, often forcing the patient 
to search for different opinions and explanations from one physi-
cian to the other.
All necessary information today can also be found on web sites.
It is understandable that the physicians get confused in explain-
ing that the disease is incurable. Despite the unease, this fact may 
not be left out or communicated only to the family (with excep-
tions in situations where it is known that the patient does not want 
to know diagnoses). The communication method always depends 
on the patient.
The communication starts only when the diagnosis has suffi-
cient foundations. It is necessary to mention the name of the dis-
ease and explain it. Positive aspects of the disease must be men-
tioned, such as for instance that it basically does not inflict pain, 
that there are no disturbs of the perception, awareness or urination 
and that it is much researched disease. At the communication of 
the diagnosis and at any other decision on palliative treatment, the 
family members must be included. If they want a second opinion, 
they need help. They also need advice in case they want to search 
for help from a healer (alternative treatments).
When symptoms of dyspnoea appear or symptoms of chronic 
hypoventilations or when the vital capacity drops to under 50%, 
the patient should be informed that he is entering the final phase of 
the disease, that is the phase of dying. This is the right time for the 
discussion about artificial respiration, living will and the determi-
nation of a health care proxy.
MUSCLE WEAKNESS 
Muscle weakness is the main symptom of ALS. Active and pas-
sive exercise is used for the prevention of involuntary contractions 
and joint stiffness, but these activities may never cause exhaustion. 
As the disease progresses, the patients may use different orthopae-
dic aids (e.g. walking sticks, crutches, foot elevators, wheelchair) but 
also other aids increasing the patient’s independence in everyday 
activities (such as special feeding aids, toilet seat aids, bath seat). It 
is necessary to introduce this topic early enough so that the patient 
and his family could get used to the idea of an aid and that they 
could accept the aid more easily when the time comes. Some pa-
tients have a short-term positive response regarding the increase of 
muscular strength by a treatment with acetilholinestrasis inhibitors.
FASCICULATION, MUSCULAR 
CONVULSIONS AND SPASMS 
Fasciculation in muscles are often the first symptom of the dis-
ease. They can develop into painful muscular convulsions. Spastic-
ity, caused by the decay of upper motoric neurons, can sometimes 
be a major problem. Both can be successfully treated, the con-
vulsions by quinidine (available as the drug SERECOR), by car-
bamazepine or phenytoin, and spasms by baclophene or tizanidine.
DYSARTHRIA
The weakness of bulbar muscles causes, among other things, 
problems in articulation (dysarthria) and the patient’s speech be-
comes hard to understand. Problems in communication are one of 
the severest consequences of the disease. Speech therapy is more 
successful in patients with slow progression of the disease. Speech 
can be replaced by electronic gadgets, the use of alphabetical cards 
is also efficient.
DYSPHAGIA
Due to problems in the movements of the tongue, the pharynx 
and the oesophagus the patient has problems with swallowing (dys-
phagia). The draughts cannot be controlled they can even reach the 
trachea (aspiration). Efficient help can be provided by adjusting the 
density of food and increasing its energy value (special collections 
of recipes are available), as well as learning different swallowing 
techniques. When this does not help and when the patient loses 
more than 10% of his body weight, it is necessary to reach a deci-
sion on the so called percutaneous endoscopic gastrostomy (PEG). 
This is a rather simple surgery performed under local anaesthesia, 
recommended before the vital capacity sinks under 50%.
DYSPNOEA
Difficulties in breathing are the hardest symptom of ALS. When 
they occur, patients often react with anxiety. The first rule of pallia-
tive treatment of dyspnoea is to break the vicious circle dyspnoea-
anxiety-dyspnoea. The presence of family members brings imme-
diate comfort, the semi-seated position and respiratory physical 
therapy help, too. It is possible to decrease the subjective feeling of 
lack of air by morphine, and anxiety can be solved by lorazepam 
drugs for instance. If morphine is carefully dosed, it practically 
never depresses breathing.
As respiratory insufficiency progresses, symptoms of chronic 
night hypoventilation occur: fatigue and sleepiness at day, concen-
tration problems, sleeping disorders, morning headaches, restless-
ness, tremor, increased perspiration, tachycardia, breathing with 
auxiliary breathing muscles, low appetite and weight loss, repeated 
inflammations of upper respiratory tracts, cyanosis, sight disor-
ders, nausea, syncope and diffuse pain in the head, neck and limbs. 
These disorders can successfully be prevented by the usage of non-
invasive intermittent (artificial) ventilation with a mask, which 
cannot always be applied in all patients. It is a temporary treatment 
aimed to an increase of the quality of life and not its prolongation. 
An alternative is the occasional administration of oxygen, which is 
worse choice due to the danger of depressing respiratory centres. A 
permanent solution can be artificial respiration by a tracheostomy, 
which is rarely the patients’ choice.
COMPULSIVE LAUGHTER/CRYING
This is a typical symptom of ALS, which must be distinguished 
from depression. It can be very embarrassing for patients if they are 
in company. The doctor should mention it and inform about treat-
ment possibilities. The first choice drug is amitriptyline; dopamine 
and lithium can also be of help.
PSYCHOLOGICAL PROBLEMS 
The patients normally react by a reactory depression at the 
communication of the diagnosis. Psychotherapy can be of help 
in this period, ideally including the whole family. Although sui-
cidal thoughts are rather common in patients suffering from ALS, 
suicides are rare. The most common cause of suicidal thoughts is 
the fear of becoming a burden to the family. The doctor should be 
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aware of depression symptoms in all phases of the disease, especial-
ly since they affect the survival and since there are efficient drugs 
against depression. Amitriptyline can, for instance, act as antide-
pressant and as a drug against sialorrhea, compulsive laughter/
crying and sleeping disorders. It is necessary to follow the mental 
health of other family members, too.
SLEEPING DISORDERS 
The most common causes of sleeping disorders are anxiety, de-
pression, inability to rotate in bed, fasciculation and muscular con-
vulsions, dysphagia with aspiration and breathing disorders. The 
treatment should first take into consideration the cause(s) of the 
disorder. It is necessary to be careful in administrating sedatives 
since they can depress breathing.
SALIVATION
Although salivation is not the consequence of excessive genera-
tion of saliva, but of the weakness of facial muscles and the muscles 
involved in swallowing, this disorder is solved by drugs and proce-
dures reducing the generation of saliva, e.g. by drugs (glycopyrro-
late, amitriptyline, trichexifenidile, clonidine), by binding the sali-
vary glands and by inactivation through irradiation or by botulin.
CONSTIPATION 
ALS is not a disease of the autonomous nervous system, and it 
does not affect the digestive tract. The constipation is usually the 
result of scarce moving and/or drugs administration (muscular 
relaxants, sedatives, anticholinergics, opiates). It can be cured by 
adjusting the diet, sufficient fluids and the use of laxatives.
PAIN 
ALS does not affect sensory nerve fibres transmitting pain, at 
least not clinically. The cause of muscular skeletal pain is the loss 
of muscular substance that used to »protect« bones and joints, and 
contractions of muscles and joints. Treatment consists in the use of 
non-steroid antirheumatics and physical therapy. Pain can also be 
caused by pressure on the skin due to a limited or absent ability to 
move. In this case it is very useful to often change the body’s posi-
tion. Should treatment with the named drugs fail, it is necessary 
to introduce opiates together with remedies against weakness (e.g. 
chlorpromazine) and laxatives.
PROBLEMS WITH MUCUS EXPECTORATION 
This is the symptom that is hardest to cure. Thicker mucus in 
the upper respiratory tracts is the consequence of decreased intake 
of liquids and lower ability of expectoration. The use of N-acetyl-
cysteine rarely helps; the patient must drink more fluids, so that 
the mucus could become thinner, but in this way more mucus is 
produced and the problem is not solved. Mucus must usually be 
removed by suction or assisted expectoration. Physical treatment 
by vibrations is successful in the initial phases of the disease.
OTHER SYMPTOMS 
Due to the weakness of the diaphragm reflecting functionally 
on the lower oesophagus sphincter, the gastrooesophagal reflux de-
velops. It is especially dangerous in PEG, when the reflux can also 
cause aspiration. It is cured by drugs for the strengthening of peri-
staltic and antacids. Since the weakened muscles no longer help in 
pumping vein blood, the limbs start swelling. Higher position of 
the legs, physical therapy and compression bandages help.
Bowel evacuation and frequent urination are signs of a spastic 
bladder. Oxibutinine helps.
Jaw pressuring can be a consequence of a pseudo bulbar injury; 
benzodiazepines help.
Laryngospasm, a sudden reflex squeezing vocal cords, can cause 
a sense of dyspnoea. Strong emotions, cold air, aspiration and other 
can be a trigger. It stops in a few seconds without intervention.   
PSYCHOSOCIAL ASSISTANCE 
This is the most important aspect of palliative care, requiring 
a multidisciplinary approach. Patients’ associations help, too. Psy-
chosocial treatment of families is as important as the care for the 
patients. An especially sensitive problem are the needs and the 
fears of the patients’ children and the assistance to patients in their 
role as parents.
SPIRITUAL CARE AND BEREAVEMENT
The term spiritual has several meanings in this context and it is 
hard to define. This is the need of defining the person in his eve-
ryday life and can, but also need not, include religious contents. 
Such spirituality can help in accepting the disease and influence the 
decision regarding PEG and artificial respiration.
Spiritual help should also include the whole family, especially 
in decreasing problems during the time of bereavement. Research 
data show that the bereavement of family members in cases of ALS 
can be especially strong and long. It can begin as soon as at the 
moment of diagnosis communication (anticipatory bereavement).
TERMINAL PHASE OR THE PHASE OF DYING 
Studies show that the majority of ALS patients die peacefully, 
mostly in their sleep, there are no cases of suffocation. If the pa-
tients do not undergo artificial ventilation, the dying process starts 
with a gentle transition from sleep into a coma due to hypercap-
nia. It is necessary in this phase to make sure the dying person 
is not suffering: restlessness and signs of dyspnoea are cured by 
morphine; since morphine is not an anxiolitic, this drug should 
sometimes be added, too. The dosage should be sufficient enough 
to remove all the symptoms. The fear of respiratory depression is 
inappropriate in the dying phase.
The majority of patients express the wish of dying at home. The 
help of hospices is the most effective way of realizing that wish. 
Patients should contact the hospice early enough.
CONCLUSION 
ALS patients normally remain rational to the end of their lives. 
This can be scary for obesrvers, and it can help hospitals in devel-
oping mechanisms of acceptance of the disease. The patients and 
their families usually want to actively participate in decisions on 
symptomatic treatments. It is the doctor’s duty to establish such a 
partner relationship.
Science will probably find a cure that will stop the disease or at 
least prolong life. This will cause a higher prevalence of the disease, 
and consequently also an increase in the needs and demands for 
optimal palliative treatments.
